Source: Breathe 2009; 5: 355



Rating:

Share or cite this content

Citations should be made in the following way:
J. Verbraecken. Time course of CPAP effects on central sleep apnoea in chronic heart failure. Breathe 2009; 5: 355

Member's Comments

No comment yet.

Related content which might interest you: Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004 Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives Year: 2005 Treatment of obstructive and central sleep apnoea in heart failure: practical options Source: Eur Respir Rev 2007; 16: 183-188 Year: 2007 Shift in sleep apnoea type in heart failure patients in the CANPAP trial Source: Eur Respir J 2010; 35: 592-597 Year: 2010 Coexistence of central sleep apnea or periodic breathing pattern in patients with congestive heart failure and obstructive sleep apnea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Sleep apnoea in chronic heart failure Source: Eur Respir Mon 2010; 50: 396-420 Year: 2010 Prevalence and impact of sleep apnoea in heart failure Source: Annual Congress 2004 - Heart failure and sleep apnoea Year: 2004 Respiratory failure in obstructive sleep apnea syndrome (OSAS)- is CPAP therapy alone adequate? Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005 Sleep apnea in patients with heart failure effectiveness of continuous positive airway pressure Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Effects of adaptive servoventilation on sleep quality in treatment emergent central sleep apnea and central sleep apnea in heart failure patients with preserved ejection fraction Source: International Congress 2017 – CPAP therapy Year: 2017 Obstructive sleep apnoea: longer respiratory event lengths in patients with heart failure Source: Eur Respir J 2013; 41: 1340-1346 Year: 2013 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure Source: Eur Respir J 2004; 24: 443-448 Year: 2004 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 The design of the Serve-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea by adaptive servo ventilation in patients with heart failure Source: Annual Congress 2008 - Outcome of adaptive servo ventilation in sleep apnoea Year: 2008 CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010 The severity of central sleep apnoea syndrome in patients with chronic congestive heart failure is dependent on the quality of medical treatment Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002